ADVANCED ENZYME TECHNOLOGIES
Back to Cashflow Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-73 Cr | ₹-59 Cr | ₹-26 Cr | ₹-49 Cr | ₹-26 Cr |
What is the latest Cash Flow from Financing Activities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-73 Cr |
| Mar2024 | ₹-59 Cr |
| Mar2023 | ₹-26 Cr |
| Mar2022 | ₹-49 Cr |
| Mar2021 | ₹-26 Cr |
How is Cash Flow from Financing Activities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-73 Cr | Negative | |
| Mar2024 | ₹-59 Cr | Negative | |
| Mar2023 | ₹-26 Cr | Negative | |
| Mar2022 | ₹-49 Cr | Negative | |
| Mar2021 | ₹-26 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,377.1 Cr | 3.1% | 2.2% | 10.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 3.1% |
2.2% |
10.6% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses